ConductScience.org, home

Paper39090255

Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing.

Al-Rabia MW and 8 others. AMB Express, 2024. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing. Papers, record 39090255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39090255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing.
PubMed
Journal
AMB Express
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
3.08, provisional
iCite
Revised in PubMed
2024-08-04
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Al-Rabia MWMohammed W
2Asfour HZHani Z
3Alhakamy NANabil A
4Bazuhair MAMohammed A
5Ibrahim TSTarek S
6Abbas HAHisham A
7Mansour BBasem
8Hegazy WAHWael A Hhttps://orcid.org/0000-0001-5683-4803
9Seleem NMNoura M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137239113Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems.Biomedicines2023https://conductscience.org/library/papers/37239113PubMed
235163939Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides.Molecules2022https://conductscience.org/library/papers/35163939PubMed
322736963Quorum sensing and bacterial social interactions in biofilms.Sensors (Basel)2012https://conductscience.org/library/papers/22736963PubMed
430559209Structural determinants driving homoserine lactone ligand selection in the Pseudomonas aeruginosa LasR quorum-sensing receptor.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30559209PubMed
515699188Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent.Microbiology (Reading)2005https://conductscience.org/library/papers/15699188PubMed
636456567Moonlighting chaperone activity of the enzyme PqsE contributes to RhlR-controlled virulence of Pseudomonas aeruginosa.Nat Commun2022https://conductscience.org/library/papers/36456567PubMed
728407429Biofilms and host response - helpful or harmful.APMIS2017https://conductscience.org/library/papers/28407429PubMed
827654605Antimicrobial Resistance.JAMA2016https://conductscience.org/library/papers/27654605PubMed
938137382The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens.Biomedicines2023https://conductscience.org/library/papers/38137382PubMed
1031462403Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.Clin Microbiol Rev2019https://conductscience.org/library/papers/31462403PubMed
1130852658Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors.Appl Microbiol Biotechnol2019https://conductscience.org/library/papers/30852658PubMed
1217026480Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?Cell Microbiol2006https://conductscience.org/library/papers/17026480PubMed
1325914685Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.Front Microbiol2015https://conductscience.org/library/papers/25914685PubMed
1438558886Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches.Saudi Pharm J2024https://conductscience.org/library/papers/38558886PubMed
1527855208Swimming Motility Mediates the Formation of Neutrophil Extracellular Traps Induced by Flagellated Pseudomonas aeruginosa.PLoS Pathog2016https://conductscience.org/library/papers/27855208PubMed
1637106705Diminishing the Pathogenesis of the Food-Borne Pathogen Serratia marcescens by Low Doses of Sodium Citrate.Biology (Basel)2023https://conductscience.org/library/papers/37106705PubMed
1721504831A strategy for antagonizing quorum sensing.Mol Cell2011https://conductscience.org/library/papers/21504831PubMed
1833349847Contribution of Swarming Motility to Dissemination in a Pseudomonas aeruginosa Murine Skin Abscess Infection Model.J Infect Dis2021https://conductscience.org/library/papers/33349847PubMed
1923499304Plasmids and the spread of resistance.Int J Med Microbiol2013https://conductscience.org/library/papers/23499304PubMed
2036361877RETRACTED: Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens.Int J Mol Sci2022https://conductscience.org/library/papers/36361877PubMed

See all 70 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42630796Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa.Can J Infect Dis Med Microbiol2026https://conductscience.org/library/papers/42630796PubMed
42567869Disarming Pseudomonas aeruginosa: repurposing vardenafil, valsartan, and olmesartan as anti-virulence and antibiofilm agents.Sci Rep2026https://conductscience.org/library/papers/42567869PubMed
41371939Disclosing New Insights on Pyrazolo[3,4-d] Pyrimidine Tethered Diverse Amino Acid Candidates as Potential DHFR Inhibitors and Anti-Virulence Agents.J Microbiol Biotechnol2025https://conductscience.org/library/papers/41371939PubMed
40871342Anti-QS Strategies Against Pseudomonas aeruginosa Infections.Microorganisms2025https://conductscience.org/library/papers/40871342PubMed
39985628Reprofiling lamivudine as an antibiofilm and anti-pathogenic agent against Pseudomonas aeruginosa.AMB Express2025https://conductscience.org/library/papers/39985628PubMed
39895767Sulforaphane Is Not Only a Food Supplement: It Diminishes the Intracellular Survival and Colonization of Salmonella enterica.ACS Omega2025https://conductscience.org/library/papers/39895767PubMed
39513857Dual Inhibition of Phosphodiesterase 3 and 4 Enzymes by Ensifentrine Protects against MRSA-Induced Lung Endothelial and Epithelial Dysfunction.Cells2024https://conductscience.org/library/papers/39513857PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39090255

GET https://conductscience.org/api/papers/v1/39090255/references?page=2